💨 Abstract

Zydus Lifesciences reported a strong financial year ending March 31, 2025. Revenue grew by 19% to Rs. 2,32,415 mn, with a net profit increase of 23% to Rs. 47,451 mn. EBITDA rose by 31% to Rs. 70,585 mn, achieving a 30.4% margin.

Courtesy: theprint.in